The human papilloma virus (HPV) vaccination programme was launched in the USA in 2006 in order to prevent HPV infection, one of the causes of cervical cancer and the second most common cancer in women ...

Interestingly, anti-vector antibodies to the TB vaccine candidate MVA85A were reported in the serum after ID but not aerosol administration in humans, suggesting that aerosol vaccination may overcome ...

Oxford researchers have developed a single-shot malaria vaccine using programmable microcapsules that release booster doses ...

Following the WHO recommendations for HPV vaccination, and in line with Mexico’s national vaccination program initiated in 2012, we focused on the vaccination’s impact among women under 25 years of ...

Table 1. Vaccine composition. Cervarix® (GlaxoSmithKline) Gardasil® (Merck) Vaccine type: HPV-16 and HPV-18 VLP L1 capsid component: HPV-6/11/16/18 VLP ...

Almost all cervical cancers are caused by human papillomaviruses (HPVs). In most cases, HPV DNA is integrated into the human genome. We found that tumor-specific, HPV-human DNA junctions are ...

Kennedy’s decision to replace ACIP wholesale and the comments he has made about deviating from standard vaccine policymaking ...

In the 1970s HPV-6 and HPV-11 were isolated and cloned from condylomas and laryngeal papillomas, respectively. At this time, Harald zur Hausen had noted that condylomas and cervical carcinomas ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by ...

Key TakeawaysThe global vaccines market reached USD 87.57 billion in 2024 and is projected to grow to USD 206.78 billion by 2035, representing a robust CAGR of 9.80%.Increasing prevalence of ...

Phase I part showed 100% Disease-Free Survival (DFS) after a minimum of 2-year follow-up - providing clinical proof of principle for TG4050 Randomization of all patients expected to be completed by en ...

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced the completion of initial patient screening in the ...